Corporate Banner
Satellite Banner
Scientific Communities
Become a Member | Sign in
Home>News>This Article

LabWare Released ELN V2.0

Published: Sunday, February 10, 2013
Last Updated: Saturday, February 09, 2013
Bookmark and Share
Latest version enhances LabWare's Enterprise Laboratory Platform strategy

LabWare has released version 2.0 of its ELN system, a key component of the company’s Enterprise Laboratory Platform (ELP) solution strategy. According to LabWare, the ELP refers to its ability to deliver an integrated and scalable solution that has the functional breadth to span broad areas of customer business operations.

LabWare ELN is an experiment and workflow driven software application that enables customers to electronically document their experiments including relevant scientific content and observations, instrument results and attachments such as spectra and chromatograms. The product works with LabWare’s flagship product, LabWare LIMS, allowing any data within LIMS to be accessible by ELN and vice versa.

In addition to its ability to automate scientific experiments, the system also provides guided Laboratory Execution System (LES) capabilities. Laboratories that work on GMP samples are required to follow standardised testing methods (STMs) when testing samples in the laboratory. LabWare ELN helps ensure that laboratory technicians are performing STMs according to the proper sequence of steps stipulated in the standard operating procedure, improving operational efficiency and enhancing regulatory compliance.

Further Information

Join For Free

Access to this exclusive content is for Technology Networks Premium members only.

Join Technology Networks Premium for free access to:

  • Exclusive articles
  • Presentations from international conferences
  • Over 3,500+ scientific posters on ePosters
  • More Than 5,200+ scientific videos on LabTube
  • 35 community eNewsletters

Sign In

Forgotten your details? Click Here
If you are not a member you can join here

*Please note: By logging into you agree to accept the use of cookies. To find out more about the cookies we use and how to delete them, see our privacy policy.

Related Content

B&W Tek and LabWare Announce Strategic Partnership
Partnership created to distribute pre-configured Raman spectroscopy template solution.
Tuesday, March 11, 2014
Scientific News
How it Works: Advanced Data Analysis Using Visualization
Visualisation of data can be used to help molecular biologists tackle the vast datasets their experiments create.
Unravelling the Role of Key Genes and DNA Methylation in Blood Cell Malignancies
Researchers from the University of Nebraska Medical Center have demonstrated the role of Dnmt3a in safeguarding normal haematopoiesis.
Salford Lung Study - The First Real World Clinical Trial
In this podcast, we learn about the Salford Lung Study and its potential to revolutionize the way we assess new drugs and treatments around the world.
Point of Care Diagnostics - A Cautious Revolution
Advances in molecular biology, coupled with the miniaturization and improved sensitivity of assays and devices in general, have enabled a new wave of point-of-care (POC) or “bedside” diagnostics.
Epigenetics and Neural Cell Death
Researchers demonstrate how deregulation of an epigenetic mechanism active in early neurogenesis phases triggers neural cell death.
Ebola-Affected Countries Receive NIH Support
The National Institutes of Health has established a new program to further research capacity to study Ebola and other epidemics.
Immunotherapy Technique Holds Promise for Curing Food Allergies
Scientists develop immunotherapy technique that almost eliminating allergic response and anaphylactic response in food-allergic mice.
Skin Patch to Treat Peanut Allergy
NIH-funded study suggests peanut protein patch is a safe and convenient method of treatment.
Molecular Origins of Dust Mite Allergy Discovered
Scientists have identified molecules of house dust mites that are targeted by the immune system of children, developing allergic rhinitis and asthma.
Scientists Uncover Why Hepatitis C Vaccine is Difficult to Make
Scientists have uncovered one reason why a successful hepatitis C vaccine continues to be elusive.
Scroll Up
Scroll Down
Skyscraper Banner

Skyscraper Banner
Go to LabTube
Go to eposters
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
3,500+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
5,200+ scientific videos